Impact of Diabetes in Patients With Acute Myocardial Infarction Undergoing Coronary Artery Bypass Surgery Within 48

Katharina Huenges1, Nele Rainer-Schmidt1, Bernd Panholzer1

  • 1Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.

PubMed

Insights

Patients with non-insulin dependent diabetes mellitus undergoing coronary artery bypass graft (CABG) surgery after acute myocardial infarction (AMI) face higher risks. Careful risk-benefit evaluation is crucial for this high-risk diabetic group.

Area of Science:

  • Cardiology
  • Diabetology
  • Surgical Outcomes

Background:

  • Coronary artery bypass graft (CABG) surgery benefits diabetic patients with coronary artery disease.
  • The benefit of CABG in diabetic patients experiencing acute myocardial infarction (AMI) remains unclear.

Purpose of the Study:

  • To evaluate the outcomes of CABG in patients with acute myocardial infarction (AMI), specifically comparing diabetic subgroups (insulin-dependent diabetes mellitus [IDDM] and non-insulin dependent diabetes mellitus [NIDDM]) with non-diabetic patients.

Main Methods:

  • Retrospective analysis of 1,427 patients who underwent CABG within 48 hours of AMI diagnosis between 2001 and 2019.
  • Categorization into non-diabetic, IDDM, and NIDDM groups.
  • Comparison of perioperative risk profiles, postoperative complications, and long-term survival rates.

Main Results:

  • Non-insulin dependent diabetes mellitus (NIDDM) patients exhibited the highest perioperative risk (EuroScore II 11.6) and increased sepsis and ventilation times.
  • NIDDM patients had a higher incidence of wound healing complications (4.7%) and the highest 30-day mortality (18.3%).
  • Long-term survival analysis up to 15 years showed significantly reduced survival in diabetic patients, particularly those with NIDDM.

Conclusions:

  • Non-insulin dependent diabetes mellitus (NIDDM) patients undergoing urgent CABG after AMI face elevated short-term and long-term complication risks.
  • A thorough risk-benefit assessment is essential for NIDDM patients considered for CABG in the context of AMI.
  • Findings highlight the need for tailored management strategies for diabetic patients undergoing revascularization post-AMI.
Abstract